Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Mylan Labs -- Ignore unavailable to you. Want to Upgrade?

To: Tenpoint who wrote (284)	4/12/1998 9:55:00 PM
From: Druggist	Read Replies (1) \| Respond to of 384

<<< He said the products could contribute close to $100 million in sales in fiscal 1999 ending March 31, compared with $10 million expected for fiscal 1998. >>> Ok, someone with more knowledge & experiance with stocks... tell me, in your opinion, how will this extend the stock price?? I was expecting that analyst to set a target, but he didn't.. Also, Mylan is appearing more and more in Medicine Shoppe's Contract buying, and my wife (a pharmacist) told me she is seeing more Mylan coming in at her job also.. These are not the newer cost drugs, these are drugs in which Mylan is being VERY price competitive to get on contract... Druggist